Verastem Inc (VSTM)
9.41
+0.20
(+2.12%)
USD |
NASDAQ |
Apr 26, 14:41
Verastem Cash from Operations (TTM): -86.46M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -86.46M |
September 30, 2023 | -73.40M |
June 30, 2023 | -71.89M |
March 31, 2023 | -64.68M |
December 31, 2022 | -63.67M |
September 30, 2022 | -56.99M |
June 30, 2022 | -52.74M |
March 31, 2022 | -53.46M |
December 31, 2021 | -53.50M |
September 30, 2021 | -65.27M |
June 30, 2021 | -9.698M |
March 31, 2021 | -18.82M |
December 31, 2020 | -33.51M |
September 30, 2020 | -49.02M |
June 30, 2020 | -121.62M |
March 31, 2020 | -133.74M |
December 31, 2019 | -138.52M |
September 30, 2019 | -120.48M |
June 30, 2019 | -115.20M |
March 31, 2019 | -90.84M |
December 31, 2018 | -74.52M |
September 30, 2018 | -75.65M |
June 30, 2018 | -64.94M |
March 31, 2018 | -69.11M |
December 31, 2017 | -57.31M |
Date | Value |
---|---|
September 30, 2017 | -42.94M |
June 30, 2017 | -37.10M |
March 31, 2017 | -29.31M |
December 31, 2016 | -29.48M |
September 30, 2016 | -33.74M |
June 30, 2016 | -39.33M |
March 31, 2016 | -44.65M |
December 31, 2015 | -45.56M |
September 30, 2015 | -45.01M |
June 30, 2015 | -42.65M |
March 31, 2015 | -39.35M |
December 31, 2014 | -36.90M |
September 30, 2014 | -33.79M |
June 30, 2014 | -31.64M |
March 31, 2014 | -29.24M |
December 31, 2013 | -26.30M |
September 30, 2013 | -25.68M |
June 30, 2013 | -25.32M |
March 31, 2013 | -24.04M |
December 31, 2012 | -22.60M |
September 30, 2012 | -20.75M |
June 30, 2012 | -18.28M |
March 31, 2012 | -13.40M |
December 31, 2011 | -9.372M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-138.52M
Minimum
Dec 2019
-9.698M
Maximum
Jun 2021
-72.77M
Average
-64.68M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Johnson & Johnson | 22.79B |
Geron Corp | -167.74M |
Altimmune Inc | -75.81M |
Oragenics Inc | -7.291M |
Actinium Pharmaceuticals Inc | -47.34M |